Multivariate analyses showed that a platelet count ≤ 100,000/mm3, a serum AFP level >20 ng/mL, a tumor size > 3 cm, the presence of vascular invasion, and the presence of EGV were the independent risk factors that predicted poor OS rates after curative therapies (Table 3). Here, AFP is linked to neoplasm.